Results 211 to 220 of about 4,215,496 (299)

Impact of SARS-CoV-2 variant mutations on susceptibility to monoclonal antibodies and antiviral drugs: a non-systematic review, April 2022 to October 2024. [PDF]

Euro Surveill
Vukovikj M, Melidou A, Nannapaneni P, Normark T, Kraus A, Broberg EK.   +5 more
europepmc   +1 more source

Cost-Effectiveness of Antiviral Drugs to Prevent or Treat Influenza A, Influenza B, or Zoonotic Influenza

İlke Akpinar, Dagmara Chojecki
openalex   +2 more sources

Clinical features of abnormal α-fetoprotein in 15 patients with chronic viral hepatitis B after treatment with antiviral drugs. [PDF]

World J Hepatol
Jiang ML, Xu F, Li JL, Luo JY, Hu JL, Zeng XQ.   +5 more
europepmc   +1 more source

Retraction Note: Magnetic triazine-based dendrimer as a versatile nanocarrier for efficient antiviral drugs delivery. [PDF]

Sci Rep
Ahangarani-Farahani R, Bodaghifard MA, Asadbegi S.   +2 more
europepmc   +1 more source

Pharmaceutical industry payments and prescriptions of direct acting antiviral drugs for hepatitis C virus infection. [PDF]

Liver Int
Murayama A, Sigel KM, Tarras ES, Marshall DC.   +3 more
europepmc   +1 more source

Construction of recombinant fluorescent LSDV for high-throughput screening of antiviral drugs. [PDF]

Vet Res
Wang J, Ji J, Zhong Y, Meng W, Wan S, Ding X, Chen Z, Wu W, Jia K, Li S.   +9 more
europepmc   +1 more source

Analytical Profile of Antiviral Drugs-Remdesivir, Simeprevir, and Sofosbuvir: A Review

M. M. Eswarudu, P. Siva Krishna, P. Srinivasa Babu, Giddaluri Ramya Sri, K. Sravya, J. Vikhil   +5 more
openalex   +2 more sources

In-silico screening and analysis of missense SNPs in human CYP3A4/5 affecting drug-enzyme interactions of FDA-approved COVID-19 antiviral drugs. [PDF]

Sci Rep
Abdelazim AA, Maged M, Abdelmaksoud AI, Hassanein SE.   +3 more
europepmc   +1 more source

Antimicrobial resistance with a focus on antibacterial, antifungal, antimalarial, and antiviral drugs resistance, its threat, global priority pathogens, prevention, and control strategies: a review. [PDF]

Ther Adv Infect Dis
Belay WY, Getachew M, Tegegne BA, Teffera ZH, Dagne A, Zeleke TK, Wondm SA, Abebe RB, Gedif AA, Fenta A, Yirdaw G, Tilahun A, Aschale Y.   +12 more
europepmc   +1 more source

Antiviral drugs prolong survival in murine recessive dystrophic epidermolysis bullosa. [PDF]

EMBO Mol Med
Tartaglia G, Fuentes I, Patel N, Varughese A, Israel LE, Park PH, Alexander MH, Poojan S, Cao Q, Solomon B, Padron ZM, Dyer JA, Mellerio JE, McGrath JA, Palisson F, Salas-Alanis J, Han L, South AP.   +17 more
europepmc   +1 more source